These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Fetuin-A protects against atherosclerotic calcification in CKD. Westenfeld R; Schäfer C; Krüger T; Haarmann C; Schurgers LJ; Reutelingsperger C; Ivanovski O; Drueke T; Massy ZA; Ketteler M; Floege J; Jahnen-Dechent W J Am Soc Nephrol; 2009 Jun; 20(6):1264-74. PubMed ID: 19389852 [TBL] [Abstract][Full Text] [Related]
8. The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. Shroff RC; Shah V; Hiorns MP; Schoppet M; Hofbauer LC; Hawa G; Schurgers LJ; Singhal A; Merryweather I; Brogan P; Shanahan C; Deanfield J; Rees L Nephrol Dial Transplant; 2008 Oct; 23(10):3263-71. PubMed ID: 18463323 [TBL] [Abstract][Full Text] [Related]
9. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Ketteler M; Bongartz P; Westenfeld R; Wildberger JE; Mahnken AH; Böhm R; Metzger T; Wanner C; Jahnen-Dechent W; Floege J Lancet; 2003 Mar; 361(9360):827-33. PubMed ID: 12642050 [TBL] [Abstract][Full Text] [Related]
10. Fetuin-A decrease induced by a low-protein diet enhances vascular calcification in uremic rats with hyperphosphatemia. Yamada S; Tokumoto M; Tsuruya K; Tatsumoto N; Noguchi H; Kitazono T; Ooboshi H Am J Physiol Renal Physiol; 2015 Oct; 309(8):F744-54. PubMed ID: 26180236 [TBL] [Abstract][Full Text] [Related]
11. Arteriosclerosis, calcium phosphate deposition and cardiovascular disease in uremia: current concepts at the bench. El-Abbadi M; Giachelli CM Curr Opin Nephrol Hypertens; 2005 Nov; 14(6):519-24. PubMed ID: 16205469 [TBL] [Abstract][Full Text] [Related]
12. Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice. Westenfeld R; Schäfer C; Smeets R; Brandenburg VM; Floege J; Ketteler M; Jahnen-Dechent W Nephrol Dial Transplant; 2007 Jun; 22(6):1537-46. PubMed ID: 17389622 [TBL] [Abstract][Full Text] [Related]
13. Vascular calcification inhibitors in relation to cardiovascular disease with special emphasis on fetuin-A in chronic kidney disease. Suliman ME; García-López E; Anderstam B; Lindholm B; Stenvinkel P Adv Clin Chem; 2008; 46():217-62. PubMed ID: 19004191 [TBL] [Abstract][Full Text] [Related]
14. "Missing" inhibitors of calcification: general aspects and implications in renal failure. Ketteler M; Westenfeld R; Schlieper G; Brandenburg V; Floege J Pediatr Nephrol; 2005 Mar; 20(3):383-8. PubMed ID: 15549415 [TBL] [Abstract][Full Text] [Related]
15. The importance of fetuin-A in vascular calcification in children with chronic kidney disease. Makulska I; Szczepańska M; Drożdż D; Polak-Jonkisz D; Zwolińska D Adv Clin Exp Med; 2019 Apr; 28(4):499-505. PubMed ID: 30070080 [TBL] [Abstract][Full Text] [Related]
16. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Moe SM; Reslerova M; Ketteler M; O'neill K; Duan D; Koczman J; Westenfeld R; Jahnen-Dechent W; Chen NX Kidney Int; 2005 Jun; 67(6):2295-304. PubMed ID: 15882271 [TBL] [Abstract][Full Text] [Related]
17. Association of fetuin-A and cardiac calcification and inflammation levels in hemodialysis patients. El-Shehaby AM; Zakaria A; El-Khatib M; Mostafa N Scand J Clin Lab Invest; 2010 Dec; 70(8):575-82. PubMed ID: 20964498 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of vascular calcification in renal disease. Shanahan CM Clin Nephrol; 2005 Feb; 63(2):146-57. PubMed ID: 15730057 [TBL] [Abstract][Full Text] [Related]